

Conceptual breakthrough in Rhinosinusitis therapy
This new product, with ideal characteristics and properties to combat rhinosinusitis and avoid its complications, should possess some differentiating features:
- Clinical Efficacy
- Absence of side effects
- Scientific Support in all facets
As a result of this exchange of ideas among experts, a new product to treat rhinosinusitis emerges, conceptually distinct from those already being marketed.
Nasodren® is also known in other countries as Sinuforte® (see list) or Fluirespira Forte® (Spain).

